Is the future of symptomatic intracranial atherosclerotic stenosis management promising?

Dacheng Liu, Jingyi Liu, Yuan Cai, Ka Sing Lawrence Wong, Liping Liu, Dacheng Liu, Jingyi Liu, Yuan Cai, Ka Sing Lawrence Wong, Liping Liu

No abstract available

Keywords: cerebrovascular disease; clinical neurology; stroke.

Conflict of interest statement

Competing interests: None declared.

References

    1. Wang Y, Zhao X, Liu L, et al. . Prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China: the Chinese intracranial atherosclerosis (CICAS) study. Stroke 2014;45:663–9. 10.1161/STROKEAHA.113.003508
    1. Holmstedt CA, Turan TN, Chimowitz MI. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol 2013;12:1106–14. 10.1016/S1474-4422(13)70195-9
    1. Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. . Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005;352:1305–16. 10.1056/NEJMoa043033
    1. Chimowitz MI, Lynn MJ, Derdeyn CP, et al. . Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011;365:993–1003. 10.1056/NEJMoa1105335
    1. Gao S, Wang YJ, Xu AD, et al. . Chinese ischemic stroke subclassification. Front Neurol 2011;2:6 10.3389/fneur.2011.00006
    1. Hong L, Cheng X, Lin L, et al. . The blood pressure paradox in acute ischemic stroke. Ann Neurol 2019;85:331–9. 10.1002/ana.25428
    1. Xu W. High-Resolution MRI of intracranial large artery diseases: how to use it in clinical practice? Stroke Vasc Neurol 2019;4:102–4. 10.1136/svn-2018-000210
    1. Waters MF, Hoh BL, Lynn MJ, et al. . Factors associated with recurrent ischemic stroke in the medical group of the SAMMPRIS trial. JAMA Neurol 2016;73:308–15. 10.1001/jamaneurol.2015.4315
    1. Kim JS, Bang OY. Medical treatment of intracranial atherosclerosis: an update. J Stroke 2017;19:261–70. 10.5853/jos.2017.01830
    1. Wong KSL, Chen C, Fu J, et al. . Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (clair study): a randomised, open-label, blinded-endpoint trial. Lancet Neurol 2010;9:489–97. 10.1016/S1474-4422(10)70060-0
    1. Wang Y, Wang Y, Zhao X, et al. . Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. N Engl J Med 2013;369:11–19. 10.1056/NEJMoa1215340
    1. Liu L, Wong KSL, Leng X, et al. . Dual antiplatelet therapy in stroke and ICAS: subgroup analysis of chance. Neurology 2015;85:1154–62. 10.1212/WNL.0000000000001972
    1. Chaturvedi S, Turan TN, Lynn MJ, et al. . Do patient characteristics explain the differences in outcome between medically treated patients in SAMMPRIS and WASID? Stroke 2015;46:2562–7. 10.1161/STROKEAHA.115.009656
    1. Yu D-D, Pu Y-H, Pan Y-S, et al. . High blood pressure increases the risk of poor outcome at discharge and 12-month follow-up in patients with symptomatic intracranial large artery stenosis and occlusions: subgroup analysis of the CICAS study. CNS Neurosci Ther 2015;21:530–5. 10.1111/cns.12400
    1. Amarenco P, Bogousslavsky J, Callahan A, et al. . High-Dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:1374–59. 10.1016/j.jvs.2006.10.008
    1. Miao H, Yang Y, Wang H, et al. . Intensive lipid-lowering therapy ameliorates asymptomatic intracranial atherosclerosis. Aging Dis 2019;10:258–66. 10.14336/AD.2018.0526
    1. Kwon SU, Hong K-S, Kang D-W, et al. . Efficacy and safety of combination antiplatelet therapies in patients with symptomatic intracranial atherosclerotic stenosis. Stroke 2011;42:2883–90. 10.1161/STROKEAHA.110.609370
    1. Amarenco P, Albers GW, Denison H, et al. . Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial. Lancet Neurol 2017;16:301–10. 10.1016/S1474-4422(17)30038-8
    1. Schwartz GG, Steg PG, Szarek M, et al. . Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med 2018;379:2097–107. 10.1056/NEJMoa1801174
    1. Powers WJ, Rabinstein AA, Ackerson T, et al. . 2018 guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American heart Association/American stroke association. Stroke 2018;49:e46–110. 10.1161/STR.0000000000000158
    1. Zaidat OO, Fitzsimmons B-F, Woodward BK, et al. . Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial. JAMA 2015;313:1240–8. 10.1001/jama.2015.1693
    1. Miao Z, Zhang Y, Shuai J, et al. . Thirty-Day outcome of a multicenter registry study of stenting for symptomatic intracranial artery stenosis in China. Stroke 2015;46:2822–9. 10.1161/STROKEAHA.115.010549
    1. Ma N, Zhang Y, Shuai J, et al. . Stenting for symptomatic intracranial arterial stenosis in China: 1-year outcome of a multicentre registry study. Stroke Vasc Neurol 2018;3:176–84. 10.1136/svn-2017-000137
    1. Low SW, Teo K, Lwin S, et al. . Improvement in cerebral hemodynamic parameters and outcomes after superficial temporal artery-middle cerebral artery bypass in patients with severe stenoocclusive disease of the intracranial internal carotid or middle cerebral arteries. J Neurosurg 2015;123:662–9. 10.3171/2014.11.JNS141553
    1. Chung J-W, Cha J, Lee MJ, et al. . Intensive statin treatment in acute ischaemic stroke patients with intracranial atherosclerosis: a high-resolution magnetic resonance imaging study (STAMINA-MRI study). J Neurol Neurosurg Psychiatry 2020;91:204–11.
    1. Leng X, Lan L, Ip HL, et al. . Hemodynamics and stroke risk in intracranial atherosclerotic disease. Ann Neurol 2019;85:752–64. 10.1002/ana.25456

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit